Trial Profile
The efficacy and safety of irbesartan/HCTZ [hydrochlorothiazide] combination therapy as first line treatment for severe hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Apr 2011
Price :
$35
*
At a glance
- Drugs Irbesartan/hydrochlorothiazide (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 02 Nov 2006 Status change
- 08 Oct 2005 New trial record.